Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma

Barbara Jezeršek Novaković, Lučka Boltežar, Aleksander NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, 1000, SloveniaCorrespondence: Barbara Jezeršek NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Zaloška 2,...

Full description

Bibliographic Details
Main Authors: Jezeršek Novaković B, Boltežar L, Novaković A
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Therapeutics and Clinical Risk Management
Subjects:
pixantrone
b-cell non-hodgkin lymphomas
efficacy
toxicity
Online Access:https://www.dovepress.com/current-opinion-on-pixantrone-in-the-treatment-of-non-hodgkin-b-cell-l-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/current-opinion-on-pixantrone-in-the-treatment-of-non-hodgkin-b-cell-l-peer-reviewed-article-TCRM

Similar Items